HROW Dividend History & Analysis | N/A Yield
HROW has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Pharmaceuticals
| SYMBOL | MARKET CAP USD | YIELD TTM | YIELD ON COST 5y |
|---|---|---|---|
| SIGA | 312 M | 13.25% | 13.30% |
| GSK | 99,693 M | 4.86% | 5.69% |
| NVO | 196,241 M | 4.70% | 5.07% |
| VTRS | 19,215 M | 4.56% | 4.78% |
| NVS | 282,550 M | 3.06% | 6.54% |
| SYMBOL | MARKET CAP USD | GROWTH RATE | CONSISTENCY |
|---|---|---|---|
| ZTS | 32,582 M | 18.92% | 100.0% |
| NVO | 196,241 M | 22.27% | 96.2% |
| LLY | 897,716 M | 15.26% | 99.5% |
| BMY | 119,073 M | 13.97% | 92.6% |
| ROVI | 3,514 M | 25.15% | 91.3% |
4.92% Yield MRK Merck
3.59% Yield JNJ Johnson & Johnson
2.75% Yield IPN Ipsen
1.34% Yield
HROW Dividend FAQ
Harrow, Inc. (HROW) is a Nashville-based pharmaceutical company specializing in the development and commercialization of ophthalmic products within the United States. The company operates through two primary segments: Branded, which manages a portfolio of FDA-approved proprietary drugs, and ImprimisRx, which focuses on ophthalmology-specific compounded medications. Its product line addresses a broad range of ocular conditions, including cataract surgery inflammation, bacterial conjunctivitis, glaucoma, and chronic dry eye.
What is the Dividend Yield of HROW?
As of May 2026, HROW's dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 30.86.
Does HROW pay a dividend?
As of May 2026 HROW does not pay a dividend.
How often does HROW pay dividends?
Over the last 12 months, HROW has issued dividend payments.
HROW dividend forecast
Based on historical data, the forecasted dividends per share for HROW for the next payments are between 0 (+0.0%) and 0 (+0.0%). This suggests the dividend will remain relatively stable. The expected Yield for the next 12 months is about -%.
Will HROW pay dividends in 2026?
The next Ex-Dividend date for Harrow Health (HROW) is currently unknown.
What is the next Ex-Dividend Date for HROW?
The next Ex-Dividend date for Harrow Health (HROW) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.
What is the Dividend Growth of HROW?
HROW's average dividend growth rate over the past 5 years is -% per year.
What is the Yield on Cost of HROW?
HROW's 5-Year Yield on Cost is -%. If you bought HROW's shares at 10.03 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.
What is the Payout Consistency of HROW?
HROW Payout Consistency is 0.0%. The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
Does HROW have a good Dividend Yield?
HROW's % Dividend Yield is considered as unknown.
What is the Dividend Payout Ratio of HROW?
The Dividend Payout Ratio of HROW is unknown.
What is the Dividend Rating of HROW?
HROW's Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.
Key Metric Definitions
Annual dividend per share divided by current share price.
Percentage of earnings paid as dividends. Below 60% = safe, above 100% = unsustainable.
Percentage of Free Cash Flow paid as dividends. More reliable than Payout Ratio since it measures actual cash.
Compound annual growth rate of dividends over the last 5 years.
Reliability of dividend payments over lifetime. Penalizes cuts and pauses.
Your effective yield if you bought 5 years ago. Shows dividend growth impact over time.
Consecutive years of dividend payments. 25+ years = Dividend Aristocrat.
Proprietary score (0-100) combining yield, growth, safety and consistency.
Last update: 2026-05-17 02:15 UTC